Who is dennis slothower review

In any case, newsletters -- unlike brokerage firms -- provide an independent and unbiased perspective, since they are unmotivated by the prospect of investment banking business. The first step in my investigation was to query the Hulbert Financial Digest database for any other newsletters besides Slothower's that currently own NFI in their model portfolios.

This is my first step in researching a stock because placing a stock in a model portfolio is the highest tribute a newsletter editor can give a stock -- higher, in fact, than a "buy" or even a "strong buy" rating. The fact that another newsletter editor agrees with Slothower about NFI is a positive sign.

The next step in my examination: Find out if any other newsletters have recently sold NFI from their model portfolios. It would have been a warning flag if there were. But there was none among the plus newsletters tracked by the HFD over the last year. It turns out that both have beaten the stock market with their respective letters -- not just with the two of their services whose model portfolios currently own NFI, but each of their other newsletters as well.

The only exception is Collins' Biotech Investor Insight--though because the HFD has tracked this letter only since last summer, the jury is still out. As the final step I turned to the stock screening services that appraise hundreds, if not thousands, on a single rating scale. These screening services are already a valuable source of insight, and they will become increasingly important in the months and years to come -- since the settlement between the large Wall Street brokerage firms and New York Attorney General Eliot Spitzer compels those firms to regularly report the conclusions reached by independent research.

The best-known of these independent firms -- Value Line, Inc. But a handful of others that the HFD tracks do. Kiener has been in practice in Reno since He received his M. His general surgery training was at Cook…. From Business: Our personalized treatment plans allows us to provide optimal therapy for adults and children with asthma, hay fever and other allergic disorders.

We also offer…. They make their own mental health issues by running a leaf blower at 8 in the morning. More Testimonials. Stealth Stocks is published by Eastman Communications, Inc. As a publisher of a financial newsletter of general and regular circulation, we cannot tender individual investment advice. Only a registered broker or investment advisor may advise you individually on the suitability and performance of your portfolio or specific investments.

In making any investment decision, you will rely solely on your own review and examination of the facts and the records relating to such investments. Past performance of our recommendations is not an indication of future performance. The publisher shall have no liability of whatever nature in respect of any claim, damages, loss or expense arising out of or in connection with the reliance by you on the contents of our Web site, any promotion, published material, alert or update.

The editor, publisher, and directors of Stealth Stocks flatly promise no front-running.